Prevalence and comorbidities associated with retinopathy in a specialized institution in Armenia Colombia
DOI:
https://doi.org/10.33975/riuq.vol34nS4.1023Keywords:
Ophthalmology, Diabetic Retinopathy;, Hypertensive RetinopathyAbstract
Introduction: Hypertensive retinopathy and diabetic retinopathy constitute a public health problem because they generate avoidable visual impairment, however, the current prevalence, its associated factors in the region and its situation within the framework of the Comprehensive Health Care Routes are unknown (RIAS) for hypertension and diabetes that have established referral to ophthalmology as a follow-up of target organ damage.
Objective: To describe the characteristics and comorbidities of Hypertensive and Diabetic retinopathy, in patients who consulted ophthalmology in Quindío during 2018.
Methods: A descriptive cross-sectional study was carried out, based on the histories of patients who consulted a specialized institution in Quindío during 2018. Variables were described in mean, standard deviation and confidence intervals, a comparative analysis was made by sex, analysis of variance and Chi square were performed.
Results: The prevalence of diabetic retinopathy was 1.65% and of hypertensive retinopathy 0.22%. 62.06% had non-proliferative diabetic retinopathy (NPDR) and 37.93% had proliferative diabetic retinopathy (PDR).
Conclusions: More diabetic retinopathy is identified and hypertensive retinopathy is almost undiagnosed. And the number of patients who consult for eye diseases has been increasing during the last 3 years in a specialized center in the city of Armenia.
Downloads
References
Hendrick AM, Gibson M V., Kulshreshtha A. Diabetic Retinopathy. Prim Care ClinOffPract. 2015 Sep ;42(3):451–64.
Mohamed Q, Gillies MC, Wong TY. Management of Diabetic Retinopathy. JAMA. 2007 Aug 22;298(8):902.
Ministerio de Salud y Protección Social. Análisis de Situación de Salud Visual en Colombia. Conv 519 del 2015. 2016;49–56.
Erden S, Bicakci E. Hypertensive retinopathy: incidence, risk factors, and comorbidities. ClinExpHypertens. 2012; 34: 397–401.
Triantafyllou A, Anyfanti P, Zabulis X, Gavriilaki E, Karamaounas P, Gkaliagkousi E y cols. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients. J Am SocHypertens 2014; 8:542–49.
Wong TY, Mitchell P. Hypertensive Retinopathy. N Engl J Med. 2004 Nov 25 ;351(22):2310–7.
Ministerio de Salud y Protección Social. Rutas integrales de atención en Salud (RIAS). Resolución 3202 del 2016. 2016
Ministerio de Salud y Protección Social. Guía de Práctica Clínica para el manejo de la hipertensión arterial primaria. 2017.
Ministerio de Salud y Protección Social. Guía de práctica clínica para el diagnóstico, tratamiento y seguimiento de la diabetes mellitus tipo 2 en la población mayor de 18 años. 2015.
Yasir ZH, Hassan A-D, Rajiv K. Diabetic retinopathy (DR) among 40 years and older Saudi population with diabetes in Riyadh governorate, Saudi Arabia – A population based survey. Saudi J Ophthalmol. 2019.
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, y cols. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012 Mar;35(3):556–64.
Zehetner C, Kirchmair R, Kralinger M, Kieselbach G. Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy. Acta Ophthalmol. 2013 Sep;91(6):e470-3.
Yaslam M, Al Adel F, Al-Rubeaan K, AlSalem RK, Alageel MA, Alsalhi A, y cols. Non-mydriatic fundus camera screening with diagnosis by telemedicine for diabetic retinopathy patients with type 1 and type 2 diabetes: a hospital-based cross-sectional study. Ann Saudi Med. 2019;39(5):328–36.
Romero-Aroca P, Sagarra-Alamo R, Pareja-Rios A, López M. Importance of telemedicine in diabetes care: Relationships between family physicians and ophthalmologists. World J Diabetes 2015; 6(8): 1005-8.
Bamashmus MA, Gunaid AA, Khandekar RB. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study. Indian J Ophthalmol. 2009;57(4):293–8.
International Council of Ophtalmology (ICO). (2017). Guías Clínicas para el manejo de la patología ocular del diabético. International Council of Ophtalmology, 1–50.
Kolman SAM, van Sijl AM, van der Sluijs FA, van de Ree MA. Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension. J Hum Hypertens. 2017 Feb 28;31(2):121–5.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Revista de Investigaciones Universidad del Quindío
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
